EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

Cancer Medicine

ISSN 2045-7634 · Wiley

Latest articles

  1. Quality of Life Outcomes From the Phase 3 Study of Atezolizumab + Bevacizumab and Chemotherapy ( ATTLAS , KCSG ‐ LU19 ‐04) in EGFR / ALK ‐Mutated Non–Small‐Cell Lung Cancer

    Eun Joo Kang, Sehhoon Park, Tae Min Kim, Ji‐Youn Han, Gyeong‐Won Lee, Byoung Yong Shim, Yun‐Gyoo Lee, Sang‐We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang‐Gon Park, Ki Hyeong Lee, Ju Won Kim, Seong‐Hoon Shin, Chan‐Young Ock, Byung‐Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn

    Published: 2026-11DOI: 10.1002/cam4.72405

  2. Increased Incidence and Improved Survival of Ewing and Ewing‐Like Sarcomas in Children and Young Adolescents in the Netherlands Since the 1990s: A Population‐Based Study

    Hanna J. M. Schep‐Wijnveen, Lianne M. Haveman, Maya Schulpen, Marijn H. Geyskens, Otto Visser, Lizz van der Heijden, Arthur J. A. T. Braat, Laura S. Hiemcke‐Jiwa, Raquel Dávila Fajardo, Simone A. J. ter Horst, Sheila C. E. J. Terwisscha van Scheltinga, Rutger R. G. Knops, Jos A. M. Bramer, Hendrik W. B. Schreuder, Michiel A. J. van de Sande, Johannes H. M. Merks, Henrike E. Karim‐Kos

    Published: 2026-11DOI: 10.1002/cam4.72429

  3. Association of Care Coordination and Discontinuity With Patterns of Care and Outcomes in Childhood Cancer Survivors With Multiple Chronic Conditions: A Report From the Childhood Cancer Survivor Study

    Claire Snyder, Rebecca Eary, Wendy M. Leisenring, Kayla L. Stratton, Cynthia M. Boyd, Lorraine T. Dean, Melissa M. Hudson, Eric J. Chow, Kevin C. Oeffinger, Elyse R. Park, Maura M. Kepper, Sara Malone, I‐Chan Huang, Matthew J. Ehrhardt, Vikki Nolan, Gregory T. Armstrong, Paul C. Nathan, Youngjee Choi

    Published: 2026-11DOI: 10.1002/cam4.72432

Volumes

2026 · 6282025 · 9842024 · 1,1802023 · 1,8812022 · 4722021 · 8352020 · 9162019 · 7602018 · 6152017 · 2972016 · 3882015 · 2072014 · 1702013 · 1052012 · 42

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.